Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent

Ecancermedicalscience
An Mt Van NuffelGauthier Bouche

Abstract

Clarithromycin (CAM) is a well-known macrolide antibiotic available as a generic drug. CAM is traditionally used for many types of bacterial infections, treatment of Lyme disease and eradication of gastric infection with Helicobacter pylori. Extensive preclinical and clinical data demonstrate a potential role for CAM to treat various tumours in combination with conventional treatment. The mechanisms of action underlying the anti-tumour activity of CAM are multiple and include prolonged reduction of pro-inflammatory cytokines, autophagy inhibition, and anti-angiogenesis. Here, we present an overview of the current preclinical (in vitro and in vivo) and clinical evidence supporting the role of CAM in cancer. Overall these findings justify further research with CAM in many tumour types, with multiple myeloma, lymphoma, chronic myeloid leukaemia (CML), and lung cancer having the highest level of evidence. Finally, a series of proposals are being made to further investigate the use of CAM in clinical trials which offer the greatest prospect of clinical benefit to patients.

Citations

Mar 8, 2016·International Immunopharmacology·Kehan LiXuechang Han
Feb 19, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sarah AwanAndrew Wilcock
Jun 7, 2015·Annals of Hematology·Bronagh McCabeKen I Mills
Aug 5, 2017·British Journal of Haematology·Andrés J M FerreriMarkus Raderer
Apr 30, 2019·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yang Kyung ChoBalamurali Ambati
Jan 10, 2020·The Journal of Biological Chemistry·Amita GuptaChaitan Khosla
May 30, 2020·Hematological Oncology·Barbara Kiesewetter, Markus Raderer
Dec 14, 2018·Frontiers in Pharmacology·Daniel HeudoblerAlbrecht Reichle
Apr 5, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bernardo L RapoportRonald Anderson
May 11, 2018·Journal of Medical Case Reports·Kern Y ChaiIan M Morison
Sep 1, 2017·Translational and Clinical Pharmacology·Masashi OheMitsuru Sugiura
Jul 19, 2017·Marine Drugs·Wei TianKui Hong
Jan 20, 2019·Current Topics in Medicinal Chemistry·Kamakshi DanduCh Mohan Rao
May 12, 2020·Molecular & Cellular Oncology·Giulia Petroni
Nov 8, 2019·Seminars in Cancer Biology·Ramanathan KaruppasamyDaisuke Kihara
Nov 5, 2019·Biochimica Et Biophysica Acta. Reviews on Cancer·Urvi H GalaRobert O Williams
Nov 19, 2020·Breast Cancer : Targets and Therapy·Andrea Luque-BolivarMilena Rondón-Lagos
Dec 4, 2020·Pharmaceuticals·Alejandro Cabrera-AndradeEduardo Tejera
Jun 7, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bárbara CostaNuno Vale
Jun 3, 2021·International Journal of Molecular Sciences·Kamila BuzunAnna Bielawska
Sep 23, 2021·Science Translational Medicine·C Glenn BegleyMark Sullivan

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Clinical Trials Mentioned

NCT01745588
NCT01559935
NCT02248428
NCT01516606
NCT00327132
NCT01264822

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Related Papers

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
J P GisbertC Martín de Argila
International Journal of Clinical Pharmacology and Therapeutics
M Hassan-AlinK Röhss
© 2022 Meta ULC. All rights reserved